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We have studied the cutaneous response to ultraviolet radiation, measured objectively as erythema in a sample of
12 body sites on 15 Northern European subjects with multiple doses of ultraviolet B (UVB). Skin pigmentation and
the development of photoadaptation in response to ﬁve repeated doses of irradiation at three body sites was also
measured. We report striking differences of up to 5-fold at different body sites to the same challenge dose
(po0.001) and demonstrate that for this population, site variation is just as important as between-person variation.
Skin color at each body site is a strong predictor of response (po0.001) and that this cannot be attributed to
vascular differences, but instead we believe it reﬂects site-specific variations in melanin pigmentation. We also
observed similar but smaller within-person effects for responses to another inﬂammatory agent, dithranol
(po0.01). Despite this, we did not ﬁnd evidence for differences in the development of photoadaptation by body site.
These results have clear clinical implications for the practice of phototesting prior to commencing phototherapy,
for therapeutic failure in sites such as the legs in patients with psoriasis, and perhaps for melanoma body-site
distribution.
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Two methods are widely used to summarize and rank dif-
ferent persons’ response to ultraviolet radiation (UVR). The
minimal erythema dose (MED), and the Fitzpatrick photo-
type (Rees, 2002). The former is based on an assessment of
a binary outcome, namely whether a particular degree of
erythema occurs after exposure to a graded series of doses
of UVR (Farr and Diffey, 1984; Farr and Diffey, 1986). The
particular degree of erythema chosen as the endpoint varies
among researchers. Reading of the MED is confounded by
differences in pigmentation (i.e., the difficulty of recognizing
erythema in the presence of different amounts of pigment)
(Diffey and Robson, 1992), and because it is a threshold
measure, the exact value of the MED depends on the dose
increment chosen for the graded series of irradiation (Farr
et al, 1989; Lock-Andersen and Wulf, 1996). It is usually
performed at one body site only.
The second method, the Fitzpatrick phototype, is based
on subjects’ recall of their response to natural sunlight in
terms of whether, and to what degree, they tan and develop
erythema (Fitzpatrick, 1988). The response is summarized
on an ordinal scale. The Fitzpatrick classification has found
wide use in clinical practice, for instance, prior to photo-
therapy and in epidemiological examination of the risk
between sunshine and skin cancer. Studies of reliability or
validity are few, but suggest that the classification has a low
reproducibility (Rampen et al, 1988; Lock-Andersen and
Wulf, 1996; Gordon et al, 1998). Unlike the MED, the meas-
ure is explicitly based on two qualities, erythema and pig-
mentation, and implicitly (if not explicitly) refers to more than
one body site.
These two methods attempt to measure different as-
pects of the skin’s response to UVR (Rees, 2002). The MED
is a single snapshot of the erythema response to a single
dose of UVR. By contrast, the Fitzpatrick scale attempts to
summarize a dynamic response and involves pigmentation
as well as erythema. It is worth outlining the rationale for the
use of either measure prior to starting phototherapy. World-
wide, people vary by at least one to two orders of magni-
tude in their sensitivity to UVR measured as erythema
following a single exposure. Even within Northern European
populations, a 4–5-fold variation occurs (Farr and Diffey,
1984; Ha et al, 2003). The differences following repeated
exposures have been poorly studied, but it seems reason-
able to assume that they are also large as it is widely ac-
cepted that people tan to different degrees and at different
rates. Since excessive doses of UVR may induce burning,
the goal in determining the starting dose for phototherapy is
to choose a dose of UVR that is not large enough to cause
burning—but is as large as it is possible otherwise—and to
increase the dose incrementally within the same con-
straints. It is also widely assumed that the degree of dose
escalation can be greater in those who tan well, as tanning
is protective against the development of erythema. The re-
lation between acute erythema response and the propensity
to tan—whatever the strength of this relation—determines
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the degree of covariance between the two measures (Rees,
2002).
In this paper, we examine experimentally how robust
these clinical beliefs are by asking three related questions.
First, how does variation in erythemal response to UVR be-
tween people compare with variation in response within a
person at different body sites? Some work has been carried
out previously on such variation on one or two body sites,
but no systematic attempt made to relate variation at a
range of anatomical sites, to the variation seen between
persons (Rhodes and Friedmann, 1992; Gordon et al, 1998).
Second, irrespective of the absolute degree of erythema
induced in response to a single dose of UVR at different
body sites, do different body sites photoadapt to the same
degree in response to repeated irradiation? Third, given site
variation in response to single doses of UVR, can such dif-
ferences be explained by site variation in pigmentation or
other characteristics such as site variation in vascular re-
sponsiveness?
Results
Different body sites show large differences in sensitivity
to UVR Ten areas, at 12 different body sites, on both left
and right sides in 15 patients were irradiated giving a total of
3600 potential data points (1800 on each side). The
correlations between the paired data points provide some
information about reproducibility. Table I lists Spearman cor-
relations (r) between paired body sites, and shows that
while correlations were as expected, high values for the
inner forearm and outer forearm were the lowest. Although
ten different doses of UVR were given at each paired body
site for all individuals, given the known variability in response,
many of these responses were zero as anticipated. Formal
analyses were therefore carried out for the top dose (300 mJ
per cm2), and are presented in most detail. We also exam-
ined the top 4 doses, incorporating dose as an explanatory
factor and graphically present the results based on the MED.
A mixed-effects model was fitted to the highest UVR
dose data, with site and sex treated as fixed effects, and
person and side as random effects. Adding higher order
functions did not appreciably alter results. It can be seen
that there is a large site effect (Table II), and that there is also
Table I. Spearman’s correlation coefﬁcient (q) for left side to
right side comparisons by body site for whole dataset
Body site Correlation
Chest 0.96
Front upper arm 0.92
Inner forearm 0.60
Front thigh 0.92
Outer calf 0.71
Upper back 0.96
Lower back 0.95
Back of upper arm 0.92
Outer forearm 0.74
Back of thigh 0.95
Abdomen 0.98
Table II. Summary of statistical model ﬁtted for the degree of
erythema induced by 300 mJ UVB
df F-value p-value
(Intercept) 1 131.3174 o0.0001
Sitea 11 60.2171 o0.0001
Sexa 1 0.0342 0.8561
Site  sexa 11 1.3934 0.1743
aThe symbol ‘‘  ’’ refers to statistical interactions between (fixed)
factors.
Figure 1
Examples of erythemal response for three body sites for all per-
sons. Three representative body sites are shown, with the erythemal
response measured in reflectance units to a dose of 300 mJ per cm2.
Numbers refer to each test subject. Note the spread of responses at
each site (particularly the forearm), and the difference between sites
(indicated by the arrows).
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considerable variation between persons, but with a minor
degree of variation accounted for by side, (person (SD)¼33;
side (SD)¼1.5; residual (SD)¼33, with an overall mean of
98). These results can be seen in context in Fig 1 in which
the response in reflectance units for the highest dose of
UVR is shown for three body sites, chosen to represent the
range of sites examined. The numbers 1–15 refer to the 15
persons studied. It is clear that not only do responses for
persons (for any site) differ, but that sites also differ, and that
variation even within some sites is very large (e.g., forearm).
By contrast, Fig 2 shows the ranking of response within
each person by site, for all 15 persons. The clustering on the
legs shows that for most persons, the leg is among the least
sensitive sites. By contrast the chest and upper back are for
most people among the most sensitive sites. Some sites
such as the inner forearm are more variable, meaning that
the ranking of sites by sensitivity within a person is not
identical for all persons (probably mirroring the interactions
with site seen in the formal analyses). Examination of a
model incorporating the highest 4 doses, as expected,
shows a large F value for dose and site but with a number of
interactions between dose, site, and sex (Table III). We
would caution against over-interpretation of this model be-
cause of poor fit to encompass many zeroes, but would
also add that such interactions are plausible in the light of
the MED data discussed below.
In order to relate these findings to clinical practice, Fig 3
shows the MED threshold measure for all body sites
examined for all 15 persons. The y-axis is in (absolute) flux
units, the vertical lines represent each of the 15 persons,
and the different symbols refer to various body sites. The
spread of points on each vertical line provides a measure of
the spread of MED at each body site for each person, and
the different ordering of the symbols between lines (i.e.,
between persons) reflects differences in the ranking of sites
between persons. The checked line links the inner forearm, a
site used in some units for phototesting, and shows the ab-
solute range of doses required to elicit the MED (read off the
y-axis) and the different position in the ranking of the various
body sites in different persons. Figure 3 makes clear that the
ranking of sites within persons shows some variation.
Within-person pigmentary differences explain some
site variation in UVR-induced erythema Pigmentary differ-
ences between people are a major determinant of erythemal
responses (Wagner et al, 2002; Ha et al, 2003). In order to
examine whether pigmentary differences at different body
sites explain some of the variation in UVR sensitivity at dif-
ferent body sites, we related erythema (reflectance) to mel-
anin index (MI) at the various sites examined for the highest
dose (300 mJ per cm2). The simple linear regression of ery-
thema on MI was highly significant for each of the four
individuals studied (all po0.001 with R2 of 0.75–0.83). Use
of the MI in such a way, however, assumes no systematic
Figure 2
Ranking of body site sensitivity to ultraviolet radiation for all sub-
jects. All 12 body sites are shown, with the left side representing the
anterior body and the right side the posterior body. Within each site are
a total of 15 symbols, one for each subject. The type of symbol shows
how THAT person at THAT site ranks within ALL the subjects (  , upper
third ranking; &, middle third; and b for the lowest third). Note how
sites like the upper back are the most sensitive and the lower leg
the least sensitive for most persons, but sites like the forearm are
more mixed.
Table III. Summary of statistical model ﬁtted for the degree of
erythema induced by the upper four doses of UVB
df F-value p-value
(Intercept) 1 101.9203 o0.0001
Dose 3 305.7786 o0.0001
Site 11 233.8745 o0.0001
Sex 1 0.0358 0.8528
Dose  sitea 33 2.4939 o0.0001
Dose  sexa 3 1.7035 0.1644
Site  sexa 11 4.6317 o0.0001
Dose  site  sexa 33 0.7870 0.8009
aThe symbol ‘‘  ’’ refers to statistical interactions between (fixed)
factors.
UVB, ultraviolet B.
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differences in blood flow that would confound the reflect-
ance measure of pigment. In order to exclude this possi-
bility, laser Doppler basal readings at a number of sites in
nine individuals were taken. We found no relation between
basal blood flow and MI nor between peak blood flow fol-
lowing UVR and basal blood flow (data not shown). We took
these experiments to exclude the possibility that the relation
between melanin pigment and erythema at different body
sites was confounded by differences in basal blood flow.
Experiment 2: photoadaptation Photoadaptation was oper-
ationally defined as the difference in flux response to a unit
dose of UVR between an area of skin that has been pre-
viously treated with UVR (on five occasions over 5 d—see
Materials and Methods) and a paired skin site that had not
been irradiated before.
In order to ensure that there was no residual change in
blood flow, due to the previous irradiations on the photo-
adapted site, baseline flux readings were taken. No differ-
ences were evident (data not shown). Examples of the
results are shown in Fig 4. For most challenged doses,
photoadapted sites showed a 2–3-fold reduction in mean
erythema, and examples for the highest doses are shown
(Fig 4, all po0.01 paired t-tests). We were unable to detect
any obvious differences between sites in the degree of
photoadaptation nor any obvious relation between the
Figure 3
Minimal erythema dose (MED) readings for all subjects by body site. Each of the body sites is represented by a different symbol and plotted
along a vertical line for each subject (x-axis). The position of a symbol on the y-axis refers to the absolute erythema dose corresponding to the MED.
Any site that failed to respond to any UVR dose is shown in the shaded gray area at the bottom of the figure. The symbol for the inner forearm (O) is
joined by a dotted line for reference. Note the variation between body site MED, the differences between persons, and the different ordering of sites
within different persons (e.g., the forearm shown by the checked line).
Figure 4
Response to ultraviolet radiation measured as Doppler flux fol-
lowing photoadaptation. Flux responses following challenge at three
paired body sites are shown (a, back; b, arms; c, legs). Each subject is
shown by a different symbol and lines link photoadapted with non-
photoadapted paired body sites (all pairwise comparisons po0.001,
paired t tests). Note that the dose used on the leg was larger than on
the other sites (600 mJ per cm2 vs 300 mJ per cm2).
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individual’s skin type and response, but would suggest
larger studies will be required to explore such effects in
detail.
Experiment 3: dithranol Because we found large differences
between body sites in the erythemal response to UVR, we
wish to examine whether this was a generalized phenom-
enon or something specific to UVR. Figure 5 shows the
dose responses measured as increase in blood flux, for
different doses of dithranol on the lower legs and back. It is
immediately apparent that there are differences with, like
UVR, the legs being less sensitive. The back produced
consistently higher Doppler flux readings than the legs at all
doses in all volunteers, with a 2-fold difference at the high-
est three doses (po 0.0001, paired t-tests; Fig 5).
Conclusions
Using an experimental approach with attention to exposure
dosimetry and objective reading of response, we have
shown systematic differences between body sites in the
response to UVR. We have also confirmed the well-known
differences in response between persons (Wagner et al,
2002; Ha et al, 2003). Within the group of Northern Euro-
peans we studied, there was approximately a 4-fold differ-
ence between persons and a 5-fold difference within
persons at different body sites. Obviously, if a group with
a broader genetic ancestry (with respect to skin color) had
been selected, the range between persons would have
been larger. We will discuss these results under two head-
ings: mechanistic causes of variation to UVR, and implica-
tions for clinical practice and future work.
The major determinant of response to UVR between dif-
ferent people is skin color (Wagner et al, 2002; Ha et al,
2003), itself a proxy for the photoprotective effects of
melanin (Rees, 2003). It is therefore not surprising that we
have also shown that even within a person, site variation in
skin color accounts for some of the variation in the vascular
response to UVR. We believe that this reflects site variation
in melanin, and that we have excluded confounding due to
differences in basal flux; but our results with dithranol, al-
though not as striking as those seen with UVR, and the
study not as detailed, suggest that other factors need to be
considered. Dithranol sensitivity was least on the legs, like
UVR sensitivity, and although the pharmacology of dithranol
inflammation is distinct (Lawrence and Shuster, 1985a, b),
our results suggest that some common mechanism needs
to be identified to explain these results. We are aware of
some work incriminating skin color (or skin type) in the di-
thranol response but we feel more work is required (King-
ston and Marks, 1983; Maurice and Greaves, 1983) (LN,
KW, JLR, unpublished).
Although there were large differences in response to UVR
by body site, photoadaptation did not obviously differ at the
various sites examined. This surprised us and we would
suggest that whatever the initial UVR sensitivity, repeated
irradiation causes photoadaptation to track along the
‘‘same line’’ at different body sites. Again, future studies
need to explore this further, particularly the fact that the
degree of basal pigmentation is different at the various sites.
Clinical relevance and future work We believe our results
have major implications for the way the clinical usefulness
of phototesting is viewed prior to phototherapy. Indeed,
given the site variation within a person, it might be tempting
to imagine that our results suggest that it is unlikely to be
helpful. How do we reconcile our data with the widespread
use of phototesting? In practice, phototesting is carried out
on some of the most sensitive body sites (such as the back),
and usually a lower dose (say 50%–70%) of the MED is then
used as a guide to therapy. This ensures that the patient
does not usually burn (on one of the most sensitive sites).
Many, if not most, other body sites are of course less sen-
sitive and will—in erythemal standards—receive a far lower
biological dose (perhaps as low as 10%). Furthermore, it is
likely that since our data suggest some differences in body
site ranking with respect to sensitivity between persons, the
degree to which this occurs will differ between persons. Our
data demonstrate that discussing dosing of phototherapy
with respect to some threshold measure such as the MED
at a particular body site has little meaning when applied to
the whole patient. A dose that is erythemal in one region
is not in another, and the difference may be 5-fold or more.
We would note in passing that the familiar clinical observa-
tion that psoriasis on the lower legs responds less well
to phototherapy may be related to the low sensitivity of the
legs to UVR.
Finally, although we have used erythema as an endpoint,
a series of questions must now be asked about other bi-
ological endpoints. Erythema, or blood flux, has the great
virtue that is easy to measure and non-invasive, allowing
multiple and complex designs. It also has a lot of biological
coherence to it: the action spectrum for erythema and DNA
damage are similar; patients with DNA repair defects, such
as xeroderma pigmentosa, show abnormal erythema
responses; and the erythemal action spectrum is a good
predictor of non-melanoma skin cancer rates in animals
(Young, 1997; Young et al, 1998; Urbach, 1999; de Gruijl,
2000). Nonetheless, our data need to be followed up using
other markers of UVR damage, for example, apoptosis and
UVR effects on the cutaneous immune function. Our data
Figure 5
Dithranol dose–response curves for two body sites. Response to
various challenge doses measured in flux units for back (~) and legs
(&). Error bars refer to standard error of the mean. Pairwise compar-
isons are po0.01 for the three highest doses.
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may also be relevant to attempts to interpret the relation be-
tween UVR and the different body site distributions of me-
lanoma and non-melanoma skin cancers (Green et al, 1993).
Materials and Methods
All studies had appropriate ethics committee approval and were
made in the light of the declaration of Helsinki (http://www.wma.
net/e/policy/b3.htm) and subsequent amendments on the World
Medical Association web site (http://www.wma.net/e/). All volun-
teers gave informed, signed consent for the study in which they
participated. None of the volunteers received fees for taking part in
any experiment.
Experiment I: variation in erythemal response at different body
sites Fifteen healthy individuals resident in Edinburgh, Scotland,
were recruited during October and November. None of the partic-
ipants had been exposed to vacational UVR (or sun beds) for at
least 3 mo prior to taking part. The age range was 23–48 y (median,
36 y), and there were eight males and seven females.
Phototesting protocol The irradiation source was a 12.5 cm broad-
band UVB lamp (Philips PLS 9 W per 12) housed in a fully enclosed
luminaire designed and built under the supervision of Professor
Brian Diffey, Regional Medical Physics, Newcastle, UK. Ten closely
spaced apertures, each 8 mm  12 mm, were milled into the lamp
diffuser to enable ten different doses to be delivered simultane-
ously. The apertures were arranged in a horseshoe design of five
doses to a side, with the lowest dose roughly parallel to the highest
dose, so that all doses were within an area 7 cm  3 cm. One
aperture was open; the rest were backed with metal foil filters,
each perforated with a grid of holes of differing sizes (the highest
dose administered with an open aperture). The filters were de-
signed to increase the UVB incrementally with doses of 38, 47, 60,
75, 95, 119, 150, 189, 238, and 300 mJ per cm2 (3
p
2 increments).
The lamp casing is of UV opaque transparent plastic, thus avoiding
the need for additional lamp shielding. The unit also contained a
digital photodiode that switched off the lamp automatically when
the correct dose at the open aperture was delivered. All doses
used are traceable to national standards.
All participants were phototested at the following 24 body sites:
right and left pectoral area, right and left anterior abdominal wall,
right and left bicep area, right and left tricep area, right and left
flexural forearm, right and left extensor forearm, right and left upper
back, right and left lower back, right and left anterior thigh, right
and left posterior thigh, right and left lateral calf, and right and left
medial calf.
The UVR lamp was handheld against the body and the UVB
delivered with the open aperture to the upper right region of each
site. The top and bottom of the phototesting unit was ‘‘land-
marked’’ with ink at each site to ensure symmetry of application
between left and right sides of the body.
Erythema measurements Twenty-four hour post-irradiation of
each body site was assessed visually for erythema, and any vis-
ible erythema plus one lower dose site (to catch non-visible ery-
thema) was objectively measured in triplicate using a reflectance
instrument (Dia-Stron, Andover, Hampshire, UK). UVR-induced
erythema was expressed as the erythema index derived from re-
flectance spectroscopy (log 10[632 nm per 546 nm]  1000) (Diffey
et al, 1984).
A baseline recording was also taken in triplicate from non-irra-
diated skin laterally adjacent to the lowest delivered dose at each
body site. A mean value was calculated from the three measure-
ments, along with the mean of the baseline recordings. The ery-
themal response was described as the change in erythema index
(baseline values subtracted). The MED, defined as the dose of UVR
required to produce a barely perceptible erythema, was also re-
corded (Lock-Andersen and Wulf, 1996).
In four of the volunteers, the MI was measured in triplicate at
each site in the same location as the baseline erythema recordings
made using the Dia-stron machine. The MI measurement is a
function of remittance at 632 nm (for melanin absorption) and 905
nm (the reference signal) (Flanagan et al, 2001; Ha et al, 2003). On
this scale, increase in pigmentation leads to a higher MI, and there
is a strong inverse relation between MI and erythema in response
to a defined dose of UVR between individuals (i.e., the MI is a
useful predictor of an individual’s sensitivity defined as erythema to
UVR) (Ha et al, 2003).
Experiment II: photoadaptation Fourteen healthy volunteers,
seven male and seven female, resident in Edinburgh, Scotland,
age range 22–49 y (median, 35 y), were recruited into the study.
Seven persons also took part in experiment I, and the history of
their vacational UVR exposure was as for experiment I. Partici-
pants were skin typed according to the Fitzpatrick scale. Two per-
sons were type I, eight type II, one type III, two type IV, and one
type VI phototype. The individual with type VI skin failed to respond
to any UVR and was excluded from any subsequent analysis.
Photoadaptation protocol Each subject was irradiated at three
body sites (chosen to be representative of the range of responses
seen in experiment I), upper left back (anterior scapular region, 5
cm from spine); inner left forearm (midway from wrist to elbow),
and outer left calf (midway from ankle to knee). The UVR source
was a Waldmann 801 BL (Herbert Waldmann GmbH & Co., KG,
Villingen-Schwenningen, Germany) bank of ten Philips TL 20 W/01
55 cm each fitted into a multi-directional hood. Volunteers were
positioned so that the area to be irradiated was parallel to and of
equal distance from the tubes. The area irradiated measured 11.5
cm  5 cm and the surrounding skin was protected with UVR
opaque fabric. Each area was marked with ink at the edges to
ensure same site re-application.
Irradiation was performed daily for 5 d (Monday–Friday) with the
dose increments being based on the work of Diffey, and are those
used routinely for phototherapy of psoriasis in our unit. The doses
used were as follows: 0.3, 0.33, 0.36, 0.39, and 0.43 J per m2,
corresponding to standard erythemal doses (SED’s) of 1.5, 1.67,
1.83, 2.05, and 2.23. (The SED (Diffey et al, 1997), is an interna-
tional standard measure of UVR weighted by the erythema action
spectrum). The starting dose would be expected to produce ery-
thema below detection with the human eye (but measurable in-
strumentally) for an individual with skin types I or II. The UVB was
delivered to the upper back with the subject prone, to the outer calf
with subject lying on alternate sides, and to the outer forearm with
the subject sitting upright. Ninety-six hours after the last irradiation,
the three areas of skin plus adjacent (matching) areas (right upper
back, inner forearm, and outer calf) were ‘‘challenged’’ with five
incremental doses of TL12 UVB using the device described above
in experiment I only with the lower five doses blocked off with UVR
opaque card (as they would not be expected to induce erythema
based on the finding of experiment I).
Twenty-four hours after challenge, measurements of blood flow
were taken with a contact laser Doppler flowmeter instrument
(moorLAB satellite, Moor Instruments Ltd., Axminster, UK). This
method, rather than a reflectance device, was used because of the
spectra for melanin and hemoglobin overlap, and therefore use of
color as a proxy for blood flow is invalid if, as in this case, basal
pigment may have changed. Doppler flux is expressed as an ar-
bitrary number in ‘‘flux units’’ (Farr and Diffey, 1986).
Because experiment I and other pilot data show that the lower
legs are less sensitive to UVR than most other body sites, the legs
were challenged with increased doses of UVB so that measurable
erythema was obtained. Because there was overlap in the dosing
regimes, comparisons can also be made with the other body sites
examined.
Experimental III: site variation in sensitivity to dithranol Nine
volunteers took part in experiment III. There were eight females and
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one male, one of whom took part in experiment I (median age, 44 y,
range, 16–54 y). Doubling doses of dithranol (0.005%, 0.01%,
0.02%, 0.04%, and 0.08%, and final volume of 0.15 mL) in Lassar’s
paste (zinc oxide, 24%; salicylic acid, 2%; starch, 24% in white
soft paraffin, 50%) were applied to left and right mid-back and left
and right outer calves. A control of Lassar’s paste only was used at
each site, and all applications were occluded under 8 mm Finn
chambers (Epitest Ltd, Hyryla, Finland) and secured in situ for 24 h
with Mepore tape (Tendra, Mo¨lnlycke Health Care AB (Publ),
Go¨teborg, Sweden (www.tendra.com)).
The resulting erythema at each dose site (including control) was
measured at 48 h with contact laser Doppler flowmetry along with
baseline flux measurements taken from a site closely adjacent to
the control dose. Laser Doppler flowmetry was used because of
the potential for confounding by pigmentation. Erythema was de-
fined as the increase in flux units after baseline measurements
were subtracted from the flux at test sites.
Experiment IV: baseline blood ﬂux at different body sites To
further determine whether variation in dermal microvasculature and
basal pigmentation at different body sites varied to a degree which
might partly explain any variation in the erythemal response to
UVR-induced erythema, nine volunteers had basal blood flow
measurements at nine body sites (right and left pectoral area,
abdomen, biceps, flexural forearms, anterior thighs, upper back,
extensor forearms, posterior thighs, and lateral calves) using the
contact laser Doppler, and the MI was measured.
Data handling and statistical analyses Data were tabulated in
Microsoft Excel (Microsoft, Seattle, USA) and imported into S-Plus
6 Version 2 (Insightful Inc, Seattle, USA www.insightful.com).
Details of the statistical models used are described in the Results
section.
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